SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-019221
Filing Date
2024-05-14
Accepted
2024-05-14 16:05:10
Documents
64
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1597082
2 ex31-1.htm EX-31.1 11128
3 ex31-2.htm EX-31.2 11085
4 ex32-1.htm EX-32.1 7280
5 ex32-2.htm EX-32.2 6966
  Complete submission text file 0001493152-24-019221.txt   8116868

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE sigy-20240331.xsd EX-101.SCH 38394
7 XBRL CALCULATION FILE sigy-20240331_cal.xml EX-101.CAL 46201
8 XBRL DEFINITION FILE sigy-20240331_def.xml EX-101.DEF 167054
9 XBRL LABEL FILE sigy-20240331_lab.xml EX-101.LAB 348707
10 XBRL PRESENTATION FILE sigy-20240331_pre.xml EX-101.PRE 304975
68 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1687152
Mailing Address 9190 W OLYMPIC BLVD # 263 BEVERLY HILLS CA 90212
Business Address 9190 W OLYMPIC BLVD # 263 BEVERLY HILLS CA 90212 619-368-2000
Sigyn Therapeutics, Inc. (Filer) CIK: 0001642159 (see all company filings)

IRS No.: 472573116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55575 | Film No.: 24944187
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)